{"schema_version":"1","generated_at":"2026-11-08T06:56:27.653Z","data_as_of":"2026-11-08","url":"https://www.findmykol.com/kol/timothee-olivier","json_url":"https://www.findmykol.com/kol/timothee-olivier/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"timothee-olivier","name":"Timothée Olivier","credential":"MD","title":"Médecin adjoint agrégé (attending physician), Service d'oncologie, Département d'oncologie, HUG, since 1 November 2023","specialty":"Medicine","therapeutic_area":"Lung","therapeutic_areas":["Lung"],"institution":"Geneva University Hospitals (HUG)","institution_url":"https://www.findmykol.com/institution/geneva-university-hospitals-hug","register":{"country":"CH"}},"identifiers":{"orcid":"0000-0002-6936-5783","openalex":"A5005844055"},"summary":"Timothée Olivier is Médecin adjoint agrégé (attending physician), Service d'oncologie, Département d'oncologie, HUG, since 1 November 2023 at Geneva University Hospitals (HUG). OpenAlex indexes 127 publications with 2,019 citations (h-index 23).","overview":{"text":"Timothée Olivier is Médecin adjoint agrégé (attending physician), Service d'oncologie, Département d'oncologie, HUG, since 1 November 2023 at Geneva University Hospitals (HUG), Department of Oncology, Medical Oncology Service. The public record shows 127 publications with 2,019 citations (h-index 23), centered on Statistical Methods in Clinical Trials, Cancer Immunotherapy and Biomarkers, Pharmaceutical industry and healthcare.","bullets":["Most recent indexed publication: 2026 · Journal of clinical oncology","Top research focus: Statistical Methods in Clinical Trials"],"generated_at":"2026-11-08"},"focus":{"indications":[{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Cushing's Syndrome","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Acromegaly","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Prostate Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Bladder / Urothelial Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Statistical Methods in Clinical Trials","Cancer Immunotherapy and Biomarkers","Pharmaceutical industry and healthcare","Lung Cancer Treatments and Mutations","PARP inhibition in cancer therapy"]},"scholarship":{"works_count":127,"cited_by_count":2019,"h_index":23,"i10_index":46,"source":"works"},"trials":{"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":6,"years":{"first":2007,"last":2025},"societies":["ASCO","ASTRO","ESMO"],"shown":3,"withheld":3,"rows":[{"title":"Why the duration of cancer treatment requires a closer look: An empirical analysis of recent FDA approvals.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.11022","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.11022","status":"verified"},{"title":"Updated estimates of eligibility and response: Immune checkpoint inhibitors.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"online_abstract","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e14613","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e14613","status":"verified"},{"title":"133P Trends in incidence and mortality of lung cancer in Switzerland: Possible explanations and open questions","society":"ESMO","meeting":"ESMO Congress","year":2022,"role":"co_author","presentation_type":"poster","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.annonc.2022.02.163","source_url":"https://doi.org/10.1016/j.annonc.2022.02.163","status":"verified"}],"source":"congress"},"publications":{"total":5,"shown":5,"withheld":10,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Time-of-Day Immunotherapy: Why the Field Still Needs Randomized Evidence.","year":2026,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42896127/","status":"verified"},{"title":"Daraxonrasib in Pancreatic Cancer: From Second-Line Breakthrough to First-Line Evidence.","year":2026,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42691452/","status":"verified"},{"title":"Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41493770/","status":"verified"},{"title":"Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management.","year":2025,"journal":"CA: a cancer journal for clinicians","types":["Journal Article","Review","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40673977/","status":"verified"},{"title":"[Oncology. Antibody-drug conjugates : a challenging innovation].","year":2025,"journal":"Revue medicale suisse","types":["English Abstract","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39846099/","status":"verified"}],"most_cited":{"total":127,"shown":5,"withheld":122,"rows":[{"title":"Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","year":2022,"cited_by_count":243,"type":"article","source_url":"https://doi.org/10.1016/j.annonc.2022.11.013"},{"title":"Anticancer Drugs Approved by the US Food and Drug Administration From 2009 to 2020 According to Their Mechanism of Action","year":2021,"cited_by_count":122,"type":"article","source_url":"https://doi.org/10.1001/jamanetworkopen.2021.38793"},{"title":"Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group","year":2015,"cited_by_count":109,"type":"article","source_url":"https://doi.org/10.1016/j.ejca.2015.01.006"},{"title":"Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review","year":2024,"cited_by_count":106,"type":"review","source_url":"https://doi.org/10.1016/j.jtho.2024.03.016"},{"title":"Effect on Survival of Local Ablative Treatment of Metastases from Sarcomas: A Study of the French Sarcoma Group","year":2014,"cited_by_count":96,"type":"article","source_url":"https://doi.org/10.1016/j.clon.2014.09.010"}]},"source":"publications"},"network":{"coauthors_total":38,"shown":3,"withheld":35,"coauthors":[{"name":"Vinay K. Prasad","coauthored_works":63},{"name":"Alyson Haslam","coauthored_works":41},{"name":"Alfredo Addeo","coauthored_works":14,"profile_url":"https://www.findmykol.com/kol/alfredo-addeo"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"x","url":"https://x.com/Timothee_MD","status":"verified"}]},"mentions":{"total":2,"shown":2,"rows":[{"url":"https://www.hug.ch/oncologie/dr-timothee-olivier","platform":"other","status":"provisional"},{"url":"https://oncodaily.com/blog/133243","label":"Profiled as an OncoInfluencer to follow on social media (OncoDaily)","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"social_posts":{"stored_total":3,"shown":3,"withheld":0,"rows":[{"platform":"x","post_id":"2113624555872751638","url":"https://x.com/timothee_md/status/2113624555872751638","handle":"timothee_md","posted_at_from_id":"2026-10-23T13:32:18.022Z","collected_at":"2026-11-05T21:43:34.520Z","sources":[{"hub":"esmo26","society_slug":"esmo","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-esmo26-conference","https://kolpulse.com/kol-pulse-trial-profile-natalee"]}]},{"platform":"x","post_id":"2113527790892974103","url":"https://x.com/timothee_md/status/2113527790892974103","handle":"timothee_md","posted_at_from_id":"2026-10-23T07:07:47.453Z","collected_at":"2026-11-05T21:43:34.520Z","sources":[{"hub":"esmo26","society_slug":"esmo","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-trial-profile-natalee"]}]},{"platform":"x","post_id":"2113371262105879004","url":"https://x.com/timothee_md/status/2113371262105879004","handle":"timothee_md","posted_at_from_id":"2026-10-22T20:45:48.082Z","collected_at":"2026-11-05T21:43:34.520Z","sources":[{"hub":"esmo26","society_slug":"esmo","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-trial-profile-natalee"]}]}],"coverage":"Saved references from selected congress pages, joined through reviewed account identifiers. Not a complete X history or evidence of attendance. Post availability may change."},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"Federal diploma in oncology (diplôme fédéral d'oncologie), 2020","source_url":"https://www.hug.ch/oncologie/dr-timothee-olivier","status":"verified","collected_at":"2026-11-08"},{"value":"MD","source_url":"https://consilium-scientific.org/component/content/article/115-speakers-25/756-timothee-olivier-md","status":"provisional","collected_at":"2026-11-08"}]},"roles":{"total":2,"shown":2,"rows":[{"value":"Member, Cantonal Research Ethics Commission (CCER), Geneva (since 2023)","source_url":"https://www.hug.ch/oncologie/dr-timothee-olivier","status":"verified","collected_at":"2026-11-08"},{"value":"Co-Editor-in-Chief, ESMO Rare Cancers","source_url":"https://www.hug.ch/actualite/dr-timothee-olivier-devient-co-redacteur-chef-lesmo-rare-cancers","status":"verified","collected_at":"2026-11-08"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Privat-Docent, University of Geneva (since 2024)","source_url":"https://www.hug.ch/oncologie/dr-timothee-olivier","status":"verified","collected_at":"2026-11-08"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Guest on the 'Bread and butter oncology' podcast, discussing recent oncology papers (episode transcript listing)","source_url":"https://www.tapesearch.com/episode/5-07-plenary-session-alps-edition/9eh2Gyn7qaR9eNyw6RkdVs","status":"provisional","collected_at":"2026-11-08"}]}},"similar":[{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Pasi Janne","slug":"pasi-janne","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/pasi-janne","json_url":"https://www.findmykol.com/kol/pasi-janne/profile.json"},{"name":"Julie Brahmer","slug":"julie-brahmer","institution":"Johns Hopkins University School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/julie-brahmer","json_url":"https://www.findmykol.com/kol/julie-brahmer/profile.json"},{"name":"Enriqueta Felip","slug":"enriqueta-felip","institution":"Vall d'Hebron Institute of Oncology (VHIO)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/enriqueta-felip","json_url":"https://www.findmykol.com/kol/enriqueta-felip/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":3,"publications":10,"network":35}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-08"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-08"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-08"}},"methodology_url":"https://www.findmykol.com/about#methodology"}